Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis. [electronic resource]
Producer: 20160325Description: 780-6 p. digitalISSN:- 1815-7920
- Adult
- Antitubercular Agents -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Ethambutol -- therapeutic use
- Female
- Humans
- Isoniazid -- therapeutic use
- Male
- Mycobacterium tuberculosis -- drug effects
- Pyrazinamide -- therapeutic use
- Rifampin -- administration & dosage
- South Africa
- Sputum -- microbiology
- Treatment Outcome
- Tuberculosis, Pulmonary -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.